• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Appeals court upholds Argentum Medical loss to Noble Biomaterials

Appeals court upholds Argentum Medical loss to Noble Biomaterials

July 15, 2015 By Fink Densford

Appeals court upholds Argentum loss to Noble BiomaterialsA federal appeals court today upheld a ruling against Argentum Medical in its patent infringement battle against Noble Biomaterials.

The Federal Circuit Appeals Court denied Argentum’s bid without comment today in a per curiam decision, according to court documents.

It’s the most recent development in a longstanding feud between Argentum and Noble over Noble’s SilverSeal anti-microbial bandages, which Argentum claimed infringed on 1 of their patents.

Argentum sued Noble in late 2007; the case was dismissed by the U.S. District Court for Middle Pennsylvania on the grounds that Argentum did not have exclusive patent rights. Noble filed a counter-claim against Argentum and its management, specifically CEO Gregg Silver and president Tom Miller, claiming they had “pursued baseless litigation and falsely advised the market” that Noble infringed on the patent.

The jury decided in Scranton, Pa.-based Noble’s favor, awarding $1 million in compensatory damages, $1 million from Miller and $1.25 million from Silver, respectively, in punitive damages. The court later added a $1 million judgment against Geneva, Ill.-based Argentum for filing the patent suit in bad faith.

Argentum appealed, but lost a bid for a new trial with the U.S. District Court of Middle Pennsylvania, in which they argued that Noble failed to prove Argentum acted in bad faith and disputed the jury’s award of punitive damages. Following the 1st appeal rejection, Argentum filed a case against its former patent attorney Joseph Fuchs, and his Chicago law firm Rockey Depke & Lyons, asserting that they were negligent in their prosecution of the case against Noble.

Argentum said it paid $675,000 to Rockey (and another $900,000 to the firm it hired after it fired Rockey in July 2010), and sought judgments of $5 million in compensatory damages against Fuchs and the law firm, as well as legal costs and pre- and post-judgment interest.

That case was dismissed in July 2013 after the parties reached a settlement, according to court documents.

Filed Under: Business/Financial News, Legal News Tagged With: Argentum Medical, Noble Biomaterials

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy